Global Cerebrovascular Disease Market 2018-2024: Opportunities, Future Trends, Growing Demand, Analysis, Forecast & Industry Developments

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 91
This report focuses on the global Cerebrovascular Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cerebrovascular Disease development in United States, Europe and China.

Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.
According to Centers for Disease Control and Prevention, cerebrovascular disease is the fourth most common cause of death in the U.S. Following North America, European countries are also expected to show steady growth in the market. In the next few years, Asia-Pacific would show remarkable growth in the cerebrovascular disease market as it is developing at a very rapid pace. The factors which would fuel the growth of the market in Asia Pacific are increasing awareness about cerebrovascular disease, certain family history related to the disease and rapidly developing technologically advanced treatments.
In 2017, the global Cerebrovascular Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    Johnson & Johnson
    Amgen
    GlaxoSmithKline
    Sanofi-Aventis
    Merck
    Sangamo BioSciences
    Aldagen
    ...

Market segment by Type, the product can be split into
    Carotid Endarterectomy
    Carotid Angioplasty Or Carotid Artery Stenting
    Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)

Market segment by Application, split into
    Academic & Research Institutes
    Pharmaceutical & Biotechnology Companies
    Hospitals & Diagnostic Centers
    Contract Research Organizations
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Cerebrovascular Disease status, future forecast, growth opportunity, key market and key players.
    To present the Cerebrovascular Disease development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cerebrovascular Disease are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Cerebrovascular Disease Market Size Growth Rate by Type (2013-2025)
        1.4.2 Carotid Endarterectomy
        1.4.3 Carotid Angioplasty Or Carotid Artery Stenting
        1.4.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
    1.5 Market by Application
        1.5.1 Global Cerebrovascular Disease Market Share by Application (2013-2025)
        1.5.2 Academic & Research Institutes
        1.5.3 Pharmaceutical & Biotechnology Companies
        1.5.4 Hospitals & Diagnostic Centers
        1.5.5 Contract Research Organizations
        1.5.6 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Cerebrovascular Disease Market Size
    2.2 Cerebrovascular Disease Growth Trends by Regions
        2.2.1 Cerebrovascular Disease Market Size by Regions (2013-2025)
        2.2.2 Cerebrovascular Disease Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Cerebrovascular Disease Market Size by Manufacturers
        3.1.1 Global Cerebrovascular Disease Revenue by Manufacturers (2013-2018)
        3.1.2 Global Cerebrovascular Disease Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
    3.2 Cerebrovascular Disease Key Players Head office and Area Served
    3.3 Key Players Cerebrovascular Disease Product/Solution/Service
    3.4 Date of Enter into Cerebrovascular Disease Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Cerebrovascular Disease Market Size by Type (2013-2018)
    4.2 Global Cerebrovascular Disease Market Size by Application (2013-2018)

5 United States
    5.1 United States Cerebrovascular Disease Market Size (2013-2018)
    5.2 Cerebrovascular Disease Key Players in United States
    5.3 United States Cerebrovascular Disease Market Size by Type
    5.4 United States Cerebrovascular Disease Market Size by Application

6 Europe
    6.1 Europe Cerebrovascular Disease Market Size (2013-2018)
    6.2 Cerebrovascular Disease Key Players in Europe
    6.3 Europe Cerebrovascular Disease Market Size by Type
    6.4 Europe Cerebrovascular Disease Market Size by Application

7 China
    7.1 China Cerebrovascular Disease Market Size (2013-2018)
    7.2 Cerebrovascular Disease Key Players in China
    7.3 China Cerebrovascular Disease Market Size by Type
    7.4 China Cerebrovascular Disease Market Size by Application

8 Japan
    8.1 Japan Cerebrovascular Disease Market Size (2013-2018)
    8.2 Cerebrovascular Disease Key Players in Japan
    8.3 Japan Cerebrovascular Disease Market Size by Type
    8.4 Japan Cerebrovascular Disease Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Cerebrovascular Disease Market Size (2013-2018)
    9.2 Cerebrovascular Disease Key Players in Southeast Asia
    9.3 Southeast Asia Cerebrovascular Disease Market Size by Type
    9.4 Southeast Asia Cerebrovascular Disease Market Size by Application

10 India
    10.1 India Cerebrovascular Disease Market Size (2013-2018)
    10.2 Cerebrovascular Disease Key Players in India
    10.3 India Cerebrovascular Disease Market Size by Type
    10.4 India Cerebrovascular Disease Market Size by Application

11 Central & South America
    11.1 Central & South America Cerebrovascular Disease Market Size (2013-2018)
    11.2 Cerebrovascular Disease Key Players in Central & South America
    11.3 Central & South America Cerebrovascular Disease Market Size by Type
    11.4 Central & South America Cerebrovascular Disease Market Size by Application

12 International Players Profiles
    12.1 Johnson & Johnson
        12.1.1 Johnson & Johnson Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Cerebrovascular Disease Introduction
        12.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2013-2018)
        12.1.5 Johnson & Johnson Recent Development
    12.2 Amgen
        12.2.1 Amgen Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Cerebrovascular Disease Introduction
        12.2.4 Amgen Revenue in Cerebrovascular Disease Business (2013-2018)
        12.2.5 Amgen Recent Development
    12.3 GlaxoSmithKline
        12.3.1 GlaxoSmithKline Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Cerebrovascular Disease Introduction
        12.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2013-2018)
        12.3.5 GlaxoSmithKline Recent Development
    12.4 Sanofi-Aventis
        12.4.1 Sanofi-Aventis Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Cerebrovascular Disease Introduction
        12.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2013-2018)
        12.4.5 Sanofi-Aventis Recent Development
    12.5 Merck
        12.5.1 Merck Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Cerebrovascular Disease Introduction
        12.5.4 Merck Revenue in Cerebrovascular Disease Business (2013-2018)
        12.5.5 Merck Recent Development
    12.6 Sangamo BioSciences
        12.6.1 Sangamo BioSciences Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Cerebrovascular Disease Introduction
        12.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2013-2018)
        12.6.5 Sangamo BioSciences Recent Development
    12.7 Aldagen
        12.7.1 Aldagen Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Cerebrovascular Disease Introduction
        12.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2013-2018)
        12.7.5 Aldagen Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Cerebrovascular Disease Key Market Segments
    Table Key Players Cerebrovascular Disease Covered
    Table Global Cerebrovascular Disease Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Cerebrovascular Disease Market Size Market Share by Type 2013-2025
    Figure Carotid Endarterectomy Figures
    Table Key Players of Carotid Endarterectomy
    Figure Carotid Angioplasty Or Carotid Artery Stenting Figures
    Table Key Players of Carotid Angioplasty Or Carotid Artery Stenting
    Figure Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Figures
    Table Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
    Table Global Cerebrovascular Disease Market Size Growth by Application 2013-2025 (Million US$)
    Figure Academic & Research Institutes Case Studies
    Figure Pharmaceutical & Biotechnology Companies Case Studies
    Figure Hospitals & Diagnostic Centers Case Studies
    Figure Contract Research Organizations Case Studies
    Figure Others Case Studies
    Figure Cerebrovascular Disease Report Years Considered
    Table Global Cerebrovascular Disease Market Size 2013-2025 (Million US$)
    Figure Global Cerebrovascular Disease Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Cerebrovascular Disease Market Size by Regions 2013-2025 (Million US$)
    Table Global Cerebrovascular Disease Market Size by Regions 2013-2018 (Million US$)
    Table Global Cerebrovascular Disease Market Share by Regions 2013-2018
    Figure Global Cerebrovascular Disease Market Share by Regions 2013-2018
    Figure Global Cerebrovascular Disease Market Share by Regions 2018
    Table Market Top Trends
    Table Global Cerebrovascular Disease Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Cerebrovascular Disease Market Share by Manufacturers (2013-2018)
    Figure Global Cerebrovascular Disease Market Share by Manufacturers in 2018
    Table Global Cerebrovascular Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Cerebrovascular Disease Product/Solution/Service
    Table Date of Enter into Cerebrovascular Disease Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table Global Cerebrovascular Disease Market Size Share by Type (2013-2018)
    Figure Global Cerebrovascular Disease Market Size Market Share by Type (2013-2018)
    Table Global Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table Global Cerebrovascular Disease Market Size Share by Application (2013-2018)
    Figure Global Cerebrovascular Disease Market Size Market Share by Application (2013-2018)
    Figure Global Cerebrovascular Disease Revenue Market Share by Application in 2017
    Figure United States Cerebrovascular Disease Market Size 2013-2018 (Million US$)
    Table United States Key Players Cerebrovascular Disease Revenue (2017-2018) (Million US$)
    Table United States Key Players Cerebrovascular Disease Market Share (2017-2018)
    Table United States Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table United States Cerebrovascular Disease Market Share by Type (2013-2018)
    Table United States Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table United States Cerebrovascular Disease Market Share by Application (2013-2018)
    Figure Europe Cerebrovascular Disease Market Size 2013-2018 (Million US$)
    Table Europe Key Players Cerebrovascular Disease Revenue (2017-2018) (Million US$)
    Table Europe Key Players Cerebrovascular Disease Market Share (2017-2018)
    Table Europe Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table Europe Cerebrovascular Disease Market Share by Type (2013-2018)
    Table Europe Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table Europe Cerebrovascular Disease Market Share by Application (2013-2018)
    Figure China Cerebrovascular Disease Market Size 2013-2018 (Million US$)
    Table China Key Players Cerebrovascular Disease Revenue (2017-2018) (Million US$)
    Table China Key Players Cerebrovascular Disease Market Share (2017-2018)
    Table China Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table China Cerebrovascular Disease Market Share by Type (2013-2018)
    Table China Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table China Cerebrovascular Disease Market Share by Application (2013-2018)
    Figure Japan Cerebrovascular Disease Market Size 2013-2018 (Million US$)
    Table Japan Key Players Cerebrovascular Disease Revenue (2017-2018) (Million US$)
    Table Japan Key Players Cerebrovascular Disease Market Share (2017-2018)
    Table Japan Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table Japan Cerebrovascular Disease Market Share by Type (2013-2018)
    Table Japan Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table Japan Cerebrovascular Disease Market Share by Application (2013-2018)
    Figure Southeast Asia Cerebrovascular Disease Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Cerebrovascular Disease Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Cerebrovascular Disease Market Share (2017-2018)
    Table Southeast Asia Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Cerebrovascular Disease Market Share by Type (2013-2018)
    Table Southeast Asia Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Cerebrovascular Disease Market Share by Application (2013-2018)
    Figure India Cerebrovascular Disease Market Size 2013-2018 (Million US$)
    Table India Key Players Cerebrovascular Disease Revenue (2017-2018) (Million US$)
    Table India Key Players Cerebrovascular Disease Market Share (2017-2018)
    Table India Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table India Cerebrovascular Disease Market Share by Type (2013-2018)
    Table India Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table India Cerebrovascular Disease Market Share by Application (2013-2018)
    Figure Central & South America Cerebrovascular Disease Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Cerebrovascular Disease Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Cerebrovascular Disease Market Share (2017-2018)
    Table Central & South America Cerebrovascular Disease Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Cerebrovascular Disease Market Share by Type (2013-2018)
    Table Central & South America Cerebrovascular Disease Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Cerebrovascular Disease Market Share by Application (2013-2018)
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Revenue in Cerebrovascular Disease Business (2013-2018) (Million US$)
    Figure Johnson & Johnson Revenue Growth Rate in Cerebrovascular Disease Business (2013-2018)
    Table Johnson & Johnson Recent Development
    Table Amgen Company Details
    Table Amgen Revenue in Cerebrovascular Disease Business (2013-2018)(Million US$)
    Figure Amgen Revenue Growth Rate in Cerebrovascular Disease Business (2013-2018)
    Table Amgen Recent Development
    Table GlaxoSmithKline Company Details
    Table GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2013-2018)(Million US$)
    Figure GlaxoSmithKline Revenue Growth Rate in Cerebrovascular Disease Business (2013-2018)
    Table GlaxoSmithKline Recent Development
    Table Sanofi-Aventis Company Details
    Table Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2013-2018)(Million US$)
    Figure Sanofi-Aventis Revenue Growth Rate in Cerebrovascular Disease Business (2013-2018)
    Table Sanofi-Aventis Recent Development
    Table Merck Company Details
    Table Merck Revenue in Cerebrovascular Disease Business (2013-2018)(Million US$)
    Figure Merck Revenue Growth Rate in Cerebrovascular Disease Business (2013-2018)
    Table Merck Recent Development
    Table Sangamo BioSciences Company Details
    Table Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2013-2018)(Million US$)
    Figure Sangamo BioSciences Revenue Growth Rate in Cerebrovascular Disease Business (2013-2018)
    Table Sangamo BioSciences Recent Development
    Table Aldagen Company Details
    Table Aldagen Revenue in Cerebrovascular Disease Business (2013-2018)(Million US$)
    Figure Aldagen Revenue Growth Rate in Cerebrovascular Disease Business (2013-2018)
    Table Aldagen Recent Development
    Table Global Cerebrovascular Disease Market Size by Regions (Million US$) 2018-2025
    Figure Global Cerebrovascular Disease Market Size Share by Regions (2018-2025)
    Figure Global Cerebrovascular Disease Market Size Share by Regions in 2025
    Figure United States Cerebrovascular Disease Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Cerebrovascular Disease Market Size Forecast (2018-2025)(Million USD)
    Figure China Cerebrovascular Disease Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Cerebrovascular Disease Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Cerebrovascular Disease Market Size Forecast (2018-2025)(Million USD)
    Figure India Cerebrovascular Disease Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Cerebrovascular Disease Market Size Forecast (2018-2025)(Million USD)
    Table Global Cerebrovascular Disease Market Size by Product (2018-2025) (Million US$)
    Figure Global Cerebrovascular Disease Market Size by Product (2018-2025)
    Figure Global Cerebrovascular Disease Market Size by Product in 2025
    Table Global Cerebrovascular Disease Market Size by Application (2018-2025) (Million US$)
    Figure Global Cerebrovascular Disease Market Size by Application (2018-2025)
    Figure Global Cerebrovascular Disease Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...